FDA Approved: ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES, 20 MG — Original Application (MARKSANS PHARMA LIMITED)

View source ↗

Summary

FDA approved Marksans Pharma Limited's esomeprazole magnesium delayed-release capsules, 20 mg, as a generic therapeutic option for common acid-related disorders…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Erosive Esophagitis
• Gastric Ulcer
• Gastroesophageal Reflux Disease
• Helicobacter Pylori Infection
• Pathological Hypersecretory Conditions
• Peptic Ulcer Disease
• Zollinger-ellison Syndrome

Drugs mentioned

• Esomeprazole Magnesium Delayed-Release Capsules, 20 mg (esomeprazole magnesium delayed-release capsules)

Snippet

ORIG AP for ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES, 20 MG (ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES, 20 MG)